Form 4: Pacific Biosciences Director Marshall Mohr Reports Acquisition and Disposal of Shares

Director Marshall Mohr reports acquiring and disposing of Pacific Biosciences shares, including stock options and restricted stock units.

Summary

• On June 18, 2024, Marshall Mohr, a director of Pacific Biosciences of California, Inc., reported transactions involving the company's stock.
• Mohr acquired 22,821 shares of common stock represented by Restricted Stock Units (RSUs) at a price of $0.
• These RSUs will vest on the one-year anniversary of the grant date or the next annual meeting, contingent on continued service as a director.
• Mohr also disposed of 22,821 shares of common stock.
• Additionally, Mohr acquired 32,179 stock options with an exercise price of $1.65, which vest monthly over one year, also contingent on continued service as a director.
• Following these transactions, Mohr directly owns 132,821 shares of common stock and 32,179 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing transactions by a company director. The acquisition of shares and options suggests a positive outlook, but it's not overtly bullish.

Positives

• The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.

Risks

• The vesting of RSUs and stock options is contingent on continued service as a director, which introduces a dependency on Mohr's continued involvement with the company.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules of the RSUs and stock options suggest a continued commitment from the director to the company's long-term success.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder sentiment, as they reflect a director's continued investment in the company.

Key Dates